Clik here to view.
IPRAGLIFLOZIN, NEW PATENT, WO2016173551, China State Institute of...
WO 2016173551 China State Institute of Pharmaceutical Industry; Shanghai Institute of Pharmaceutical Industry...
View ArticleClik here to view.
WO 2016181414, IVACAFTOR, NEW PATENT, COUNCIL OF SCIENTIFIC & INDUSTRIAL...
CSIR, Dr. D. Srinivasa Reddy WO2016181414, PROCESS FOR THE SYNTHESIS OF IVACAFTOR AND RELATED COMPOUNDS...
View ArticleClik here to view.
Generics: FDA´s New Guidance on Prior Approval Supplements
DRUG REGULATORY AFFAIRS INTERNATIONAL Generics: The US Food and Drug Administration (FDA) recently published a new Guidance regarding Prior Approval Supplements (PAS). Read more about FDA´s Guidance...
View ArticleClik here to view.
ZINPLAVA (BEZLOTOXUMAB), Approved FDA
BEZLOTOXUMAB Biologic License Application (BLA): 761046 Company: MERCK SHARP DOHME Drug Name(s): • ZINPLAVA (BEZLOTOXUMAB) http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761046s000lbl.pdf...
View ArticleClik here to view.
Clik here to view.
Ranolazine Intermediate, An Efficient Synthesis of...
An efficient process for the preparation of 1-(2-methoxyphenoxy)-2,3-epoxypropane, a key intermediate for the synthesis of ranolazine is described. http://pubs.acs.org/doi/suppl/10.1021/op300056k...
View ArticleClik here to view.
Designing Polymers for Amorphous Solid Dispersions — AAPS Blog
By: Laura I. Mosquera-Giraldo and Lynne S. Taylor Imagine spending billions of dollars in the discovery of a new drug, and then realizing that it is impractical to administer it orally because it...
View ArticleClik here to view.
Lumefantrine
lumefantrine 2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl]ethan-1-ol (±)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-α-((dibutylamino)methyl)fluorene-4-methanol...
View ArticleClik here to view.
CEP 33779
CEP-33779, CEP33779 CAS 1257704-57-6 Chemical Formula: C24H26N6O2S Molecular Weight: 462.57 Elemental Analysis: C, 62.32; H, 5.67; N, 18.17; O, 6.92; S, 6.93...
View ArticleClik here to view.
PIMODIVIR, VX 787
PIMODIVIR VX-787, JNJ-63623872, JNJ-872, VRT-0928787, VX-787, VX 787, VX787, JNJ-872, JNJ 872, JNJ872, VRT-0928787, VRT 0928787, VRT0928787, pimodivir...
View ArticleClik here to view.
Selection and justification of starting materials: new Questions and Answers...
DRUG REGULATORY AFFAIRS INTERNATIONAL The ICH Q11 Guideline describing approaches to developing and understanding the manufacturing process of drug substances was finalised in May 2012. Since then...
View ArticleClik here to view.
CPP 115
(+)-(1S,4S)-4-Amino-3-(difluoromethylene)-1-cyclopentanecarboxylic acid 640897-20-7 CAS PHASE 1 NORTHWESTERN UNIVERSITY .INNOVATORS Sponsor: Catalyst Pharmaceuticals, Inc. CPP-115 free base;...
View ArticleClik here to view.
Efficient atom and step economic (EASE) synthesis of the “smart drug” Modafinil
Green Chemistry International Efficient atom and step economic (EASE) synthesis of the “smart drug” Modafinil Green Chem., 2017, Advance ArticleDOI: 10.1039/C6GC02623K, Communication Shivam Maurya,...
View ArticleClik here to view.
MODANAFIL
MODANAFIL Modafinil; 68693-11-8; Provigil; Modiodal; 2-[(diphenylmethyl)sulfinyl]acetamide; Modafinilum [Latin] Molecular Formula: C15H15NO2S Molecular Weight: 273.35 g/mol Patent EP0966962 and Patent...
View ArticleClik here to view.
Glenmark Launches First and Only Generic Version of Zetia® (Ezetimibe) in the...
Illustration Image Courtesy…..link “We have launched ezetimibe, the first and only generic version of Zetia (Merck) in the United States for the treatment of high...
View ArticleClik here to view.
FDA approves Eucrisa (crisaborole) for eczema
News Release FDA approves Eucrisa for eczema The U.S. Food and Drug Administration today approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two...
View ArticleClik here to view.
DNDI-VL-2098
DNDI-VL-2098 CAS 681492-17-1 (R)-2-Methyl-6-nitro-2-(4-trifluoromethoxyphenoxymethyl)-2,3-dihydroimidazo[2,1-b]oxazole Watch this post, will be updated……….. C14 H12 F3 N3 O5, 359.26...
View ArticleClik here to view.
Citarinostat
Citarinostat Treatment of Hematological Malignancies, Molecular Formula, C24-H26-Cl-N5-O3, Molecular Weight, 467.9544, RN: 1316215-12-9 UNII: 441P620G3P...
View ArticleClik here to view.
FDA grants accelerated approval to new treatment for advanced ovarian cancer...
The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer. Rubraca is approved for women with advanced...
View ArticleClik here to view.
NEW PATENT, SUGAMMADEX, WO 2016194001
NEW PATENT, SUGAMMADEX, WO 2016194001 WO2016194001, PROCESSES FOR PREPARATION OF SUGAMMADEX AND INTERMEDIATES THEREOF ALAPARTHI, Lakshmi Prasad; (IN). PAL, Palash; (IN). GINJUPALLI, Sadasiva Rao;...
View Article